Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 021671

Expand all

DEPODUR (MORPHINE SULFATE)
10MG/ML (10MG/ML)
Marketing Status: Discontinued

Active Ingredient: MORPHINE SULFATE
Proprietary Name: DEPODUR
Dosage Form; Route of Administration: INJECTABLE, LIPOSOMAL; EPIDURAL
Strength: 10MG/ML (10MG/ML)
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N021671
Product Number: 001
Approval Date: May 18, 2004
Applicant Holder Full Name: PACIRA PHARMACEUTICALS INC
Marketing Status:  Discontinued
Patent and Exclusivity Information

DEPODUR (MORPHINE SULFATE)
15MG/1.5ML (10MG/ML)
Marketing Status: Discontinued

Active Ingredient: MORPHINE SULFATE
Proprietary Name: DEPODUR
Dosage Form; Route of Administration: INJECTABLE, LIPOSOMAL; EPIDURAL
Strength: 15MG/1.5ML (10MG/ML)
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N021671
Product Number: 002
Approval Date: May 18, 2004
Applicant Holder Full Name: PACIRA PHARMACEUTICALS INC
Marketing Status:  Discontinued
Patent and Exclusivity Information

DEPODUR (MORPHINE SULFATE)
20MG/2ML (10MG/ML)
Marketing Status: Discontinued

Active Ingredient: MORPHINE SULFATE
Proprietary Name: DEPODUR
Dosage Form; Route of Administration: INJECTABLE, LIPOSOMAL; EPIDURAL
Strength: 20MG/2ML (10MG/ML)
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N021671
Product Number: 003
Approval Date: May 18, 2004
Applicant Holder Full Name: PACIRA PHARMACEUTICALS INC
Marketing Status:  Discontinued
Patent and Exclusivity Information